TrialThe Journal of antimicrobial chemotherapy2026

A randomized controlled Phase I de-escalation trial of molnupiravir and nirmatrelvir/ritonavir combination for mild-moderate SARS-CoV-2 infection.

Saye H Khoo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.